Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release

Medical Mycology

Volumn 37, Issue 4, 1999, Pages 235-243

  Cleare, W ^a   Casadevall, Arturo ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

C. neoformans; Culture polysaccharide; Glucose; Morphology

Indexed keywords

GLUCOSE; GLUCURONOXYLOMANNAN; MONOCLONAL ANTIBODY; PLASMA PROTEIN; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ARTICLE; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; NONHUMAN; PHAGOCYTOSIS; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTIGENS, FUNGAL; CELL WALL; CRYPTOCOCCUS NEOFORMANS; GLUCOSE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MUTATION; POLYSACCHARIDES; SEROLOGIC TESTS;

FILOBASIDIELLA NEOFORMANS;

EID: 0032816794     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00226.x     Document Type: Article

References (35)

1. Bhattacharjee AK. Bennett JE, Glaudemans CP. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis 1984; 6: 619-624.
2. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Inject Immun 1994; 62: 1507-1512.
3. Cherniak R. Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol 1988; 2: 40-54.
4. Cherniak R, Morris LC, Meyer SA. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohyd Res 1992; 225: 331-337.
5. Cherniak R, Morris LC, Turner SH. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy. Carbohyd Res 1992; 223: 263-269.
6. Vartivarian SE, Anaissie EJ, Cowart RE, et al. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis 1993; 167: 186-190.
7. Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans: regulation of capsule synthesis by carbon dioxide. J Clin Invest 1985; 76: 508-516.
8. Kozel TR, Gulley WF, Cazin J. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect Immun 1977; 18: 701-707.
9. Hirano A, Zimmerman H, Levine S. The fine structure of cerebral fluid accumulation: reactions of ependyma to implantation of cryptococcal polysaccharide. J Pathol Bacteriol 1966; 91: 149-155.
10. Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest 1996; 97: 689-698.
11. Pettoello-Mantovani M, Casadevall A, Smarnworawong P, Goldstein H. Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae. AIDS Res Hum Retrovir 1994; 10: 1079-1087.
12. Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896-901.
13. Kozel TR. Pfrommer GS. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immun 1986; 52: 1-5.
14. Vecchiarelli A, Retini C, Pietrella D, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 1995; 63: 2919-2923.
15. Murphy JW. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993; 61: 4750-4759.
16. Bloomfield N, Gordon MA. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 1963; 114: 64-67.
17. Jacobson ES, Tingler MJ. Strains of Cryptococcus neoformans with defined capsular phenotypes. J Med Vet Mycol 1994; 32: 401-404.
18. Casadevall A, Mukherjee J, Devi SJ, et al. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 1992; 165: 1086-1093.
19. Cherniak R, Morris LC, Anderson BC, Meyer SA. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun 1991; 59: 59-64.
20. Dubois MG, Hamilton K, Rebers P, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-356.
21. Cleare W, Casadevall A. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A & D strains correlate with serotype classification and differences in functional assays. Clin Diagn Lab Immunol 1998; 5: 125-129.
22. Jacobson ES, Payne WR. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J Bacterial 1982; 152: 932-934.
23. Chang YC, Kwon-Chung KJ. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 1994; 14: 4912-4919.
24. Allison D, Goldsbrough M. Polysaccharide production in Pseudomonas cepacia. J Basic Microbiol 1994; 34: 3-10.
25. Bonet R, Congregado F. Effects of nutrients on exopolysaccharide production and surface properties of Aeromonas salmonicida. Appl Environ Microbiol 1993; 59: 2437-2441.
26. Edwards M, Gordon M, Lapa E, Ghiorse W. Micromorphology of Cryptococcus neoformans. J Bacteriol 1967; 94: 766-777.
27. Takeo K, Uesaka I, Uehira K, Nishiura M. Fine structure of Cryptococcus neoformans grown in vitro as observed by freeze-ectching. J Bacteriol 1973; 113: 1442-1448.
28. Sakaguchi N, Baba T, Fukuzawa M, Ohno S. Ultrastructural study of Cryptococcus neoformans by quick freezing and deep-etching method. Mycopathologia 1993; 121: 133-141.
29. Sakaguchi N. Ultrastructural study of hepatic granulomas induced by Cryptococcus neoformans by quick-freezing and deep etching method. Virchows Arch B Cell Pathol 1993; 64: 57-66.
30. Murphy JW, Hidore MR, Nabavi N. Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans. Infect Immun 1991; 59: 1476-1488.
31. Murphy JW. Slick ways Cryptococcus neoformans foils host defenses. ASM News 1996; 62: 77-80.
32. Mukherjee J, Cleare W, Casadevall A. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans. J Immunol Methods 1995; 184: 139-143.
33. Van Doom WG, Thiel F, Boekestein A. Cryoscanning electron microscopy of extracellular polysaccharides produced by bacterial colonies. Scanning 1990; 12: 297-299.
34. Kozel TR, Tabuni A, Young BJ, Levitz SM. Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells. Infect Immun 1996; 64: 2336-2338.
35. Littman ML. Capsule synthesis by Cryptococcus neoformans. N Y Acad Sci 1958; 20: 623-645.